Prospective
This
adran has no associated
Memorandwm Esboniadol
F1137. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.K.
Textual Amendments
F1Sch. 2 para. 137 omitted (31.12.2020 immediately before IP completion day) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 2 para. 38